Valence ロゴ
人気
ログイン
Loading data for QGEN — first visit, this takes a few seconds.

ウォッチリストに追加

Qiagen N.V.

NYSE: QGEN · リアルタイム株価 · USD
42.95
-0.28 (-0.65%)
終値時点： Aug 14, 2026, 8:00 PM
42.95
+0.00%
時間外: 7:34 PM

Qiagen N.V. (QGEN) Stock Price, Analysis & Data

-0.65%

データがありません

買気配41.48
時価総額8.87B
売上高（TTM）2.1B
純利益（TTM）409.32M
ベータ0.62
EPS（TTM）1.97
PER（TTM）21.8
予想PER16.46
PBR（TTM）2.64
PSR（TTM）4.22
Earnings DateNov 4, 2026
売気配45
出来高2,695,042
平均出来高（20日）2,692,914
始値43.55
前日終値43.23
当日レンジ42.77 - 43.73
52週レンジ32.53 - 57.82
アナリストn/a
目標株価n/a
配当$0.35 (0.81%)
権利落ち日2026年7月7日

QGENについて

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, inc...

[続きを読む]
業種 Diagnostics & Research
セクター Healthcare
IPO日 Jun 28, 1996
従業員数 5,500
上場取引所 NYSE
ティッカー QGEN
ウェブサイト https://www.qiagen.com
企業情報の全文

業績

2025年のQiagenの売上高は2.09Bで、前年の1.98Bから5.65%の増加でした。 利益は424.88Mで、408.28%の増加でした。

財務諸表

決算サプライズ

QiagenはAug 4, 2026に四半期決算を発表しました：
  • 売上高は $535.04M で、予想を下回りました $0, うち 0.28% の前年比増加にあたります.
  • EPSは 0.62 で、予想を上回りました 0.02, うち -1.59% の前年比減少.

    • 次回決算発表

    Qiagen N.V.の決算発表予定日は Nov 4, 2026, 取引時間中の予定です。
    アナリストの売上高予想は ... アップグレード
    news image

    4日前 · Simply Wall St.

    4% Undervalued? Qiagen (QGEN) As Q2 Beat And FDA Clearance Lift The Story

    Qiagen (QGEN) has drawn fresh attention after surpassing its own sales and EPS outlook for Q2 2026 and reaffirming full year guidance, along with FDA clearance for its QIAstat Dx BCID GPF Plus AMR Pan...

    news image

    5日前 · Insider Monkey

    Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip?

    Qiagen (NYSE:QGEN) walked into its second quarter of 2026 bracing investors for a roughly 2% sales decline. Instead, net sales came in flat at $535 million on August 6, and adjusted diluted EPS hit $0...

    news image

    5日前 · Insider Monkey

    Strong Beats Mask Zillow’s (Z) Restructuring And Headwinds

    Zillow Group (NASDAQ:Z) delivered a second quarter that beat its own outlook on nearly every line, then turned around and eliminated jobs and reshuffled its leadership team. On the call held August 5,...

    news image

    5日前 · Simply Wall St.

    Will FDA Clearance of QIAstat-Dx Bloodstream Panel Change Qiagen's (QGEN) Syndromic Testing Narrative?

    Earlier this week, QIAGEN reported second-quarter 2026 results showing essentially flat year-on-year sales at US$535.04 million but higher net income of US$103.4 million, alongside shareholder-approve...

    news image

    5日前 · Motley Fool

    Qiagen (QGEN) Q2 2026 Earnings Call Transcript

    Sales beat guidance as Sample Technologies and QIAcuity drive growth momentum.

    2ページ中1ページ